PE20001059A1 - Derivados de benzamida como inhibidores de la trombina - Google Patents

Derivados de benzamida como inhibidores de la trombina

Info

Publication number
PE20001059A1
PE20001059A1 PE1999000995A PE00099599A PE20001059A1 PE 20001059 A1 PE20001059 A1 PE 20001059A1 PE 1999000995 A PE1999000995 A PE 1999000995A PE 00099599 A PE00099599 A PE 00099599A PE 20001059 A1 PE20001059 A1 PE 20001059A1
Authority
PE
Peru
Prior art keywords
benzamide
ilamino
pyridin
alkyl
methyl
Prior art date
Application number
PE1999000995A
Other languages
English (en)
Inventor
Martin Pass
Henry Anderson Kelly
David Neil Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20001059A1 publication Critical patent/PE20001059A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE AMIDA DE FORMULA I DONDE R1 ES ALQUILO C1-C4, CICLOALQUILO C3-C8; R2 ES ALQUILO C1-C4, ALQUENILO C3-C4; R3 ES H, ALQUILO C1-C3, HALOGENO; R4 ES ALQUILO C1-C6. SON COMPUESTOSS PREFERIDOS N-ETIL-N-ISOPROPIL-3-METIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPOXI]-BENZAMIDA; N,N-DIISOPROPIL-3-METIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPOXI]-BENZAMIDA; N-ISOPROPIL-3,N-DIMETIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPROXI]-BENZAMIDA; 3,N-DIMETIL-N-PROPIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPOXI]BENZAMIDA; 3-METIL-N,N-DIPROPIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPOXI]-BENZAMIDA; N-ETIL-3-METIL-N-PROPIL-5-[2S-(PIRIDIN-4-ILAMINO)-PROPOXI]-BENZAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHIBIDOR DE LA TROMBINA POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO ENFERMEDADES VASCULARES AGUDAS, TROMBOSIS CORONARIA, ATAQUE, EMBOLIA PULMONAR, TROMBOSIS VENOSA PROFUNDA, INFARTO DE MIOCARDIO, ANGINA INESTABLE
PE1999000995A 1998-10-03 1999-09-30 Derivados de benzamida como inhibidores de la trombina PE20001059A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9821483.6A GB9821483D0 (en) 1998-10-03 1998-10-03 Chemical compounds

Publications (1)

Publication Number Publication Date
PE20001059A1 true PE20001059A1 (es) 2000-10-23

Family

ID=10839873

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000995A PE20001059A1 (es) 1998-10-03 1999-09-30 Derivados de benzamida como inhibidores de la trombina

Country Status (21)

Country Link
US (2) US6441008B1 (es)
EP (1) EP1117644A1 (es)
JP (1) JP3457281B2 (es)
KR (1) KR20010075546A (es)
CN (1) CN1328548A (es)
AR (1) AR023332A1 (es)
AU (1) AU758007B2 (es)
BR (1) BR9914267A (es)
CA (1) CA2345997A1 (es)
CO (1) CO5140085A1 (es)
CZ (1) CZ20011216A3 (es)
GB (1) GB9821483D0 (es)
HU (1) HUP0103744A3 (es)
IL (1) IL142301A0 (es)
MA (1) MA26695A1 (es)
NO (1) NO20011654L (es)
NZ (1) NZ510839A (es)
PE (1) PE20001059A1 (es)
PL (1) PL347152A1 (es)
TR (1) TR200100906T2 (es)
WO (1) WO2000020394A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117144D0 (en) * 2001-07-13 2001-09-05 Glaxo Group Ltd Process
DK1637141T3 (da) 2004-09-21 2012-02-27 Trobio Ab Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
CA2621059C (en) * 2005-09-22 2013-08-13 Trobio Ab Stabilized protease composition
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW257757B (es) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
NZ262941A (en) 1993-03-29 1997-07-27 Zeneca Ltd Pyridine derivatives and medicaments
GB9525620D0 (en) 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP3457281B2 (ja) 2003-10-14
CA2345997A1 (en) 2000-04-13
JP2002526531A (ja) 2002-08-20
BR9914267A (pt) 2001-07-03
AU758007B2 (en) 2003-03-13
US20020169189A1 (en) 2002-11-14
GB9821483D0 (en) 1998-11-25
PL347152A1 (en) 2002-03-25
AU6467099A (en) 2000-04-26
NO20011654D0 (no) 2001-04-02
MA26695A1 (fr) 2004-12-20
WO2000020394A1 (en) 2000-04-13
NZ510839A (en) 2003-08-29
US6441008B1 (en) 2002-08-27
KR20010075546A (ko) 2001-08-09
TR200100906T2 (tr) 2001-07-23
AR023332A1 (es) 2002-09-04
HUP0103744A3 (en) 2002-03-28
US6670381B2 (en) 2003-12-30
NO20011654L (no) 2001-05-30
HUP0103744A2 (hu) 2002-02-28
EP1117644A1 (en) 2001-07-25
CZ20011216A3 (cs) 2001-09-12
CO5140085A1 (es) 2002-03-22
IL142301A0 (en) 2002-03-10
CN1328548A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
PE20001283A1 (es) Inhibidor de la proteasa de serina
PE20011314A1 (es) DERIVADOS DE N-(4-CARBAMIMIDOIL-FENIL)-GLICINA COMO INHIBIDORES DE LA FORMACION DE FACTORES DE COAGULACION Xa IXa Y TROMBINA
ES2092316T3 (es) Agentes antianginosos de purinona.
PE110899A1 (es) Derivados de acidos ariloxiarilsulfonilamino hidroxamicos
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
PE20040696A1 (es) Derivados de acido mandelico como inhibidores de la formacion de factores de coagulacion
PE20001330A1 (es) Derivados de fenilglicina
PE20010635A1 (es) Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
PE20021056A1 (es) Derivados de pirazol
AR042602A1 (es) Compuestos de 1,2,4-triazol
DE60040676D1 (de) BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
NI200500106A (es) Derivados de dihidropiranoindol-3,4-diona sustituidos y derivados de 2-hidroxi-metilindol del acido 3-oxoacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
PE20000754A1 (es) Bencimidazoles y su preparacion
PE133999A1 (es) Derivados de acido hidroxamico como inhibidores de metaloproteasas de matriz (mmp)
PE108099A1 (es) Acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
PE20061153A1 (es) Compuestos heterociclicos como inhibidores del factor viia
CO4970728A1 (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados
PE20001037A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
PE1998A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
CO5160347A1 (es) Derivados de acido carbamico
ATE331709T1 (de) Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren
PE20011101A1 (es) Compuestos heterociclicos sustituidos con un grupo sulfonilo y metodos para estimular el crecimiento y elongacion de neuronas
DK1452528T3 (da) Xanthinoxidaserinhibitorer
PE20001059A1 (es) Derivados de benzamida como inhibidores de la trombina
PE20020910A1 (es) p-TIENILBENCIL-AMIDAS COMO AGONISTAS DE RECEPTORES DE ANGIOTENSINA-(1-7), PROCEDIMIENTO PARA SU PREPARACION Y PREPARADOS FARMACEUTICOS QUE LOS CONTIENEN

Legal Events

Date Code Title Description
FC Refusal